| Literature DB >> 26579385 |
Mingqian Sun1, Jianxun Liu1, Chengren Lin1, Lan Miao1, Li Lin1.
Abstract
Since alkaloids are the major active constituents of Rhizoma corydalis (RC), a convenient and accurate analytical method is needed for their identification and characterization. Here we report a method to profile the alkaloids in RC based on liquid chromatography-tandem quadrupole time-of-flight mass spectrometry (LC-Q-TOF-MS/MS). A total of 16 alkaloids belonging to four different classes were identified by comparison with authentic standards. The fragmentation pathway of each class of alkaloid was clarified and their differences were elucidated. Furthermore, based on an analysis of fragmentation pathways and alkaloid profiling, a rapid and accurate method for the identification of unknown alkaloids in RC is proposed. The method could also be useful for the quality control of RC.Entities:
Keywords: Alkaloid; Fragmentation pathway; LC–Q-TOF-MS/MS; Rhizoma corydalis
Year: 2014 PMID: 26579385 PMCID: PMC4629067 DOI: 10.1016/j.apsb.2014.04.003
Source DB: PubMed Journal: Acta Pharm Sin B ISSN: 2211-3835 Impact factor: 11.413
Figure 1Chemical structures of the four types of alkaloids in RC.
Figure 2Base peak currents (BPC) of the solution of standards (A) and extract of RC (B). Peak identities: 1, Tetrahydrocolumbamine; 2, Tetrahydrojatrorrhizine; 3, Protopine; 4, Allocryptopine; 5, Demethyleneberberine; 6, Tetrahydropalmatine; 7, Coptisine; 8, Glaucine; 9, Canadine; 10, Corydaline; 11, Columbamine; 12, Jatrorrhizine; 13, Worenine; 14, Berberine; 15, Palmatine; 16, Dehydrocorydaline.
LC–Q-TOF-MS data of alkaloids from RC.
| No. | Name | RT (min) | Formula | Mass ( | Error | Structure pattern | Fragmentation pattern | |
|---|---|---|---|---|---|---|---|---|
| Calculated | Observed | |||||||
| 1 | Tetrahydrocolumbamine | 11.8 | C20H23NO4 | 342.17 | 342.1724 | 7 | Tetrahydroprotoberberine-alkaloids | RDA |
| 2 | Tetrahydrojatrorrhizine | 12.5 | C20H23NO4 | 342.17 | 342.1724 | 7 | Tetrahydroprotoberberine-alkaloids | RDA |
| 3 | Protopine | 14.8 | C20H19NO5 | 354.1336 | 354.1358 | 6.2 | Protopine-alkaloids | RDA and H2O loss |
| 4 | Allocryptopine | 17.7 | C21H23NO5 | 370.1649 | 370.1671 | 5.9 | Protopine-alkaloids | RDA and H2O loss |
| 5 | Demethyleneberberine | 18.5 | C19H18NO4+ | 324.123 | 324.1248 | 5.6 | Protoberberine-alkaloids | CO and CH3 loss |
| 6 | Tetrahydropalmatine | 19.1 | C21H25NO4 | 356.1856 | 356.1879 | 6.4 | Tetrahydroprotoberberine-alkaloids | RDA |
| 7 | Coptisine | 20.1 | C19H14NO4+ | 320.0917 | 320.0934 | 5.3 | Protoberberine-alkaloids | CO loss |
| 8 | Glaucine | 22.1 | C21H25NO4 | 356.1856 | 356.1878 | 6.5 | Aporphine-alkaloids | NH2CH3 loss |
| 9 | Canadine | 23 | C20H21NO4 | 340.1549 | 340.1568 | 5.6 | Tetrahydroprotoberberine-alkaloids | RDA |
| 10 | Corydaline | 24.2 | C23H31NO4 | 370.2013 | 370.2033 | 5.4 | Tetrahydroprotoberberine-alkaloids | RDA |
| 11 | Columbamine | 25.1 | C20H20NO4+ | 338.1387 | 338.1414 | 8 | Protoberberine-alkaloids | CO and CH3 loss |
| 12 | Jatrorrhizine | 25.9 | C20H20NO4+ | 338.1387 | 338.1414 | 8 | Protoberberine-alkaloids | CO and CH3 loss |
| 13 | Worenine | 27.2 | C20H16NO4+ | 334.1074 | 334.1089 | 4.5 | Protoberberine-alkaloids | CO loss |
| 14 | Berberine | 30.1 | C20H18NO4+ | 336.123 | 336.1251 | 6.2 | Protoberberine-alkaloids | CO and CH3 loss |
| 15 | Palmatine | 32.4 | C21H22NO4+ | 352.1543 | 352.1568 | 7.1 | Protoberberine-alkaloids | CO and CH3 loss |
| 16 | Dehydrocorydaline | 37.5 | C22H24NO4+ | 366.17 | 366.1723 | 6.3 | Protoberberine-alkaloids | CO and CH3 loss |
| 17 | X1 | 10.3 | C21H25NO4 | 356.1856 | 356.1877 | 6.4 | Tetrahydroprotoberberine-alkaloids | RDA |
| 18 | X2 | 31.3 | C21H22NO4+ | 352.1543 | 352.1568 | 7.1 | Protoberberine-alkaloids | CO and CH3 loss |
Figure 3MS/MS spectrum and fragmentation of tetrahydropalmatine.
Figure 4MS/MS spectrum and fragmentation of corydaline.
Figure 5MS/MS spectrum and fragmentation pathway of protopine.
Figure 6MS/MS spectrum and fragmentation pathway of berberine.
Figure 7MS/MS spectrum (A) and fragmentation pathway (B) of Coptisine.
Figure 8MS/MS spectrum and fragmentation pathway of Glaucine.
Figure 9MS/MS spectrum and fragmentation pathway of unknown alkaloids X1 (A) and X2 (B).